We are fast growing company with a wide range of Pharmaceutical Products
|
Corporate Executive |
|
Director's Profile & Corporate Disclosure of Oriscon Biotech India Private Limited |
BOARD OF DIRECTORS
|
P. R. Shrivastava Director ( 1st ) K. Kumar Director ( 2nd ) |
Chairman & Managing Director Joint Director |
|
Dr. A. K. Singh Director |
Human Resources Director |
|
J. Sah Director |
Investment committee Director |
|
A.C. Verma Director |
Audit Committee Director |
|
M. K. Thakur Director |
Legal Affairs Director |
|
M. Kumar Director |
Welfare committee Director |
|
Dr. B. K. Gupta Director |
Product Research Director |
|
K. Mishra Director |
Corporate Affairs Director |
|
U. K. Thakur Outside Director |
Non executive Independent Director |
|
T. Kumar Outside Director |
Audit Committee Member |
COMPANY SECRETARY : M/S Arun Associates, New Delhi
BANKERS : (1) Punjab National Bank (2) AXIS BANK
AUDITORS : M/S Jha Shailendra & Associates , Chartered Accountants
MR. SHAILENDRA KUMAR JHA (FCA ).
|
"We are a company registered under the Indian Companies Act,1956 in the year 2006 at New Delhi . At Oriscon Biotech (I) Pvt Ltd our philosophy is to provide economically priced good quality Pharmaceutical Products to the humankind at large. We also believe that there should be no compromise on the health of a human being. Our vision is to become a significant major Pharmaceutical Company in India by providing good quality & affordable economical medicine for the treatment of all types of life threatening disease "
The authorised capital of the company has increased from Rs.40,00,000/-( Rupees Forty Lacs only) to Rs.2,00,00,000/- (Rupees Two crore only) by creation of 16,00,000 (Sixteen Lacs) New equity shares of Rs.10/- (Rupees Ten only) each. Consequently, Clause V of the Memorandum of Association and Article 3 (a) of the Articles of Association of the Company is proposed to be altered.
A Copy of Memorandum and Articles of Association of the Company together with the proposed alteration will be made available for inspection by the Members of the Company at its Registered office between 11:00 a.m. and 1:00 p.m. on any working day of the Company till the date of Annual General Meeting.
In terms of the provisions of Section (s) 16, 31and 94 consent of the Members is required for any alteration in Memorandum and Articles of Association of the Company. The Board recommends the Resolutions for your approval.
Under section 293(1)(d) of the Companies Act, 1956, the Board of Directors cannot except with the consent of the Company borrow moneys apart from temporary loans obtained from the Company's bankers in the ordinary course of business in excess of the aggregate of paid-up capital and free reserves of the Company, that is to say, reserves not set apart for any specific purpose.
The members of the Company at the Extra-ordinary General meeting held on April 20, 2010 by Special resolution authorised Board of Directors of the Company to borrow up to a limit of Rs. 2 crores. In view of increased volume of business envisaged in the forthcoming months, it is proposed to authorise the Board to borrow up to Rs2 crores and for this purpose approval of the members is sought under Section 293(1)(d) of the Act.